These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7446534)

  • 1. Mixing additives in plastic LVPs.
    Deardorff DL; Schmidt CN
    Am J Hosp Pharm; 1980 Dec; 37(12):1610, 1613. PubMed ID: 7446534
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of preparation techniques on mixing of additives in intravenous fluids in nonrigid containers.
    Deardorff DL; Schmidt CN; Wiley RA
    Hosp Pharm; 1993 Apr; 28(4):306, 309-10, 312-3. PubMed ID: 10125325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous therapy. 6. Compatibilities of drug additives.
    Williams JT; Moravec DF
    Hosp Manage; 1966 Jun; 101(6):43-4. PubMed ID: 5932207
    [No Abstract]   [Full Text] [Related]  

  • 4. Procedures for handling intravenous additives. The nursing team approach.
    Paoloni CU
    Hosp Manage; 1969 Sep; 108(3):12-22. PubMed ID: 5809799
    [No Abstract]   [Full Text] [Related]  

  • 5. The right solution: mixing I.V. drugs thoroughly.
    Motz-Harding E; Good F
    Nursing; 1985 Feb; 15(2):62-4. PubMed ID: 3844125
    [No Abstract]   [Full Text] [Related]  

  • 6. [Infusion-fluid container of pliable plastic. Risk with admixture of drug concentrations].
    Nordbo K
    Sykepleien; 1975 May; 62(10):460. PubMed ID: 1040313
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments on drugs difficult to compound and the quality of chemicals to be used in compounding.
    Perrin JH
    Drug Dev Ind Pharm; 1999 Apr; 25(4):553-7. PubMed ID: 10194613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of compounding changes in parenteral injections by thin-layer chromatography. 1].
    Tanaka K; Sakamoto Y; Nakai T
    Iryo; 1968 Oct; 22(10):1109-14. PubMed ID: 4885315
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mixing of infusions].
    Schell W
    Kinderkrankenschwester; 1999 Apr; 18(4):164-5. PubMed ID: 10514656
    [No Abstract]   [Full Text] [Related]  

  • 10. Bulk compounding technology.
    Am J Hosp Pharm; 1968 Jun; 25(6):320. PubMed ID: 5656779
    [No Abstract]   [Full Text] [Related]  

  • 11. [Deterioration of parenterals due to compounding].
    Kyakui N
    Kango Gijutsu; 1970 Feb; ():67-74. PubMed ID: 5199396
    [No Abstract]   [Full Text] [Related]  

  • 12. Facility for small volume parenteral manufacturing.
    Kelly PC
    Bull Parenter Drug Assoc; 1976; 30(2):72-9. PubMed ID: 949564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Problems with infusion mixtures in health departments].
    Malý J; Samková M
    Zdrav Prac; 1975 Oct; 25(10):597-600. PubMed ID: 1045763
    [No Abstract]   [Full Text] [Related]  

  • 14. [Quality control of infusion solutions. I. Foreign particles in infusion solutions].
    van den Bemd AA
    Pharm Weekbl; 1969 Sep; 104(39):1205-9. PubMed ID: 5345140
    [No Abstract]   [Full Text] [Related]  

  • 15. Automatic particle counters used for regulatory monitoring of particulates in LVPs: statistical analysis.
    Oxborrow GS; Nierman ML; Heisick JE; Lanier JM
    J Parenter Sci Technol; 1981; 35(5):237-41. PubMed ID: 7299600
    [No Abstract]   [Full Text] [Related]  

  • 16. Hazards surround I.V. admixtures.
    Dinel B
    Hosp Adm Can; 1978 Sep; 20(9):21, 23. PubMed ID: 10239185
    [No Abstract]   [Full Text] [Related]  

  • 17. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
    Good PD; Schneider JJ; Ravenscroft PJ
    J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution additive chemical incompatibility study.
    Parker EA
    Am J Hosp Pharm; 1967 Aug; 24(8):434-9. PubMed ID: 6075728
    [No Abstract]   [Full Text] [Related]  

  • 19. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of an IV admixture program in a 167-bed hospital.
    Wyatt BK
    Hosp Pharm; 1975 Jun; 10(6):225-9. PubMed ID: 10237880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.